Octreotide Acetate
NDC 0641-6177 · Hikma Pharmaceuticals USA Inc.
Packages
0641-6177-01 — 1 VIAL, MULTI-DOSE in 1 CARTON (0641-6177-01) / 5 mL in 1 VIAL, MULTI-DOSE
Billed under HCPCS
J2354 — Injection, octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcg Medicare Part B payment limit (ASP + 6%): $0.60
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
0078-0180 — octreotide acetate, 0078-0181 — octreotide acetate, 0078-0182 — octreotide acetate, 0641-6174 — Octreotide Acetate, 0641-6175 — Octreotide Acetate, 0641-6176 — Octreotide Acetate, 0641-6178 — Octreotide Acetate, 23155-685 — octreotide acetate, 23155-686 — octreotide acetate, 23155-687 — octreotide acetate, 23155-688 — octreotide acetate, 23155-689 — octreotide acetate, 52958-046 — octreotide acetate, 62756-452 — octreotide acetate, 63323-376 — OCTREOTIDE ACETATE, 63323-377 — OCTREOTIDE ACETATE, 63323-378 — OCTREOTIDE ACETATE, 63323-379 — OCTREOTIDE ACETATE, 67457-239 — octreotide acetate, 67457-245 — octreotide acetate, +10 more
Poisoning, adverse-effect and underdosing codes for this drug
The ICD-10-CM Table of Drugs and Chemicals carries these diagnosis codes for this drug — a drug-name match derived from FDA's product name and the Table of Drugs and Chemicals, not a CMS-published pairing.
T38.991 — Poisoning by other hormone antagonists, accidental (unintentional), T38.992 — Poisoning by other hormone antagonists, intentional self-harm, T38.993 — Poisoning by other hormone antagonists, assault, T38.994 — Poisoning by other hormone antagonists, undetermined, T38.995 — Adverse effect of other hormone antagonists, T38.996 — Underdosing of other hormone antagonists